Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-001315·LUMOS PHARMA, INC.
Schedule 13G ownership disclosure
LUMOS PHARMA INC
Common Stock · CUSIP: 55028X109
Event date: 2024-12-31
- Filing-level shares
- Unavailable
- Percent of class
- 0%
- Private Advisor Group, LLC
Shares: Unavailable · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-001315
- Form type
- SCHEDULE 13G/A
- Filer
- LUMOS PHARMA, INC.
- CIK
- CIK 1126234
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership